GreenLight Biosciences Rings the Closing Bell

ABOUT THIS EVENT

GreenLight Biosciences (Nasdaq: GRNA), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Dr. Andrey Zarur, CEO, rings the Closing Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore